Cantex is developing azeliragon, a novel antagonist of RAGE (the receptor for advanced glycation endproducts)... Cantex Pharmaceuticals, Inc. is a clinical stage pharmaceutical company developing novel, well-tolerated, oral treatments of cancer and..
Relevance: 107.29045